Doxycycline improves clinical outcomes during cystic fibrosis exacerbations. [electronic resource]
Producer: 20180227ISSN:- 1399-3003
- Adolescent
- Adult
- Alabama
- Cystic Fibrosis -- drug therapy
- Double-Blind Method
- Doxycycline -- therapeutic use
- Female
- Forced Expiratory Volume
- Humans
- Kaplan-Meier Estimate
- Linear Models
- Lung -- physiopathology
- Male
- Matrix Metalloproteinase 9 -- metabolism
- Sputum -- chemistry
- Tissue Inhibitor of Metalloproteinase-1 -- metabolism
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.